Global Pharmatech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: April 15, 2014
Pages: 50
Price:
US$ 499.00
Global Pharmatech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 140.00)
ID: G0349DB10F7EN
Leaflet:

Download PDF Leaflet

Global Pharmatech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Global Pharmatech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Global Pharmatech, Inc. and its competitors. This provides our Clients with a clear understanding of Global Pharmatech, Inc. position in the Consumer Products Industry.

  • The report contains detailed information about Global Pharmatech, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Global Pharmatech, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Global Pharmatech, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Global Pharmatech, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Global Pharmatech, Inc. business.

About Global Pharmatech, Inc.

Global Pharmatech Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, Traditional Chinese Medicine (TCM), and dietary supplements primarily in the People’s Republic of China.

Products

The company’s product line consists of 20 drugs and 2 dietary supplements. These are primarily TCM-based prescription drugs, over-the-counter drugs, and dietary supplements, including 2 western medicines.

The XS CAPSULE (XIN-SHU) is a prescription drug used for the treatment of angina and other coronary disease. The drug substances of XS were extracted from six Chinese medical herbal materials.

The JUTAI SOFT CAPSULE is a dietary supplement with 3 patents, including 1 innovation patent. Substances of this product are extracted from American ginseng and ECHINACEA PURPUREA, a plant originally grown in North America. This dietary supplement and energy provider was developed by the company. ECHINACEA PURPUREA might improve the concentration of blood leukocyte and general human immunity. In addition, Jutai is approved for sale to combat fatigue and improve general human immunity.

QINGXUAN ANTI-HYPERTENSION TABLET is an over-the-counter drug product used for the treatment of hypertension and high serum cholesterol level. The drug substance of Qingxuan is extracted from a single Chinese medical herb, radish seed. The extract contains methyl mercaptan, erucic acid, octadecatrienoic acid, nC13, Glycerol sinapate, raphanin, cyaniding, and coumarin.

YANREQING TABLET is used to treat inflammation.

In addition to these patented products, the company manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections and numbness of limbs.

Sales

The company focuses its sales efforts in Jilin, Heilongjiang, Liaoning, Inner Mongolia, Hebei, Shandong, Zhejiang, Guangdong, and other provinces in China. The company also sells to parts of southeast Asia.

Suppliers

The company’ principal capsule suppliers include Kanghua Medicine Supply Co., Ltd. and Yaofeng Capsule Co., Ltd. Changchun Xinhai Wrapping Supply Co., Ltd. is its principal source for medicine wrappers. Changchun Shenrong TCM Co., Ltd. is the company’s primary supplier of herbal raw materials.

Markets

The company provides services to medium-sized pharmaceutical companies in northern China. It also targets the sale of its products to medical institutions, such as hospitals and clinics.

Competition

The company’s principal competitors are Tongrentang and Guangzhou Pharmaceutical.

History

Global Pharmatech Inc. was founded in 2001.


RESEARCH METHODOLOGY

DISCLAIMER

1. GLOBAL PHARMATECH, INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. GLOBAL PHARMATECH, INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. GLOBAL PHARMATECH, INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. GLOBAL PHARMATECH, INC. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. GLOBAL PHARMATECH, INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Global Pharmatech, Inc. Direct Competitors
5.2. Comparison of Global Pharmatech, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Global Pharmatech, Inc. and Direct Competitors Stock Charts
5.4. Global Pharmatech, Inc. Industry Analysis
  5.4.1. Consumer Products Industry Snapshot
  5.4.2. Global Pharmatech, Inc. Industry Position Analysis

6. GLOBAL PHARMATECH, INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. GLOBAL PHARMATECH, INC. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. GLOBAL PHARMATECH, INC. ENHANCED SWOT ANALYSIS2

9. GLOBAL PHARMATECH, INC. PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. GLOBAL PHARMATECH, INC. PORTER FIVE FORCES ANALYSIS2

11. GLOBAL PHARMATECH, INC. VRIO ANALYSIS2


APPENDIX 1: RATIO DEFINITIONS


LIST OF TABLES

Global Pharmatech, Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Global Pharmatech, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Global Pharmatech, Inc. Major Shareholders
Global Pharmatech, Inc. History
Global Pharmatech, Inc. Products
Revenues by Product
Revenues by Region
Global Pharmatech, Inc. Offices and Representations
Global Pharmatech, Inc. SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Global Pharmatech, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Global Pharmatech, Inc. Capital Market Snapshot
Global Pharmatech, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Consumer Products Industry Statistics
Global Pharmatech, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Global Pharmatech, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

LIST OF FIGURES

Global Pharmatech, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Global Pharmatech, Inc. 1-year Stock Charts
Global Pharmatech, Inc. 5-year Stock Charts
Global Pharmatech, Inc. vs. Main Indexes 1-year Stock Chart
Global Pharmatech, Inc. vs. Direct Competitors 1-year Stock Charts
Global Pharmatech, Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price. Please note that preparation of additional types of analyses requires extra time.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a Project Plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as STEP, PESTLE, STEEP, STEEPLE, STEEPLED, etc.) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations;
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislations will exert influence on the style the business is carried out?

Porter Five Forces Analysis

The extended Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions followed by sixth question added to the original concept:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?
  6. Is there any complementary products, government decisions or public perception that can impact business?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to Imitate?
  • Organized Properly?
LIST OF TABLES

Global Pharmatech, Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Global Pharmatech, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Global Pharmatech, Inc. Major Shareholders
Global Pharmatech, Inc. History
Global Pharmatech, Inc. Products
Revenues by Product
Revenues by Region
Global Pharmatech, Inc. Offices and Representations
Global Pharmatech, Inc. SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Global Pharmatech, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Global Pharmatech, Inc. Capital Market Snapshot
Global Pharmatech, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Consumer Products Industry Statistics
Global Pharmatech, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Global Pharmatech, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

Ask Your Question

Global Pharmatech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: